The Medicines Company announced the launch of a new formulation of Minocin (minocycline) for Injection. The new formulation contains magnesium sulfate, an excipient, which allows for administration at ...
TOKYO, Oct 4, 2022 - (JCN Newswire) - - Eisai Co., Ltd. announced that, as part of the strategic investment towards the realization of its medium-term business plan "EWAY Future & Beyond", it has ...
EXTON, PA — ProRx Pharma is moving to disrupt one of the fastest-growing corners of the medical wellness industry with the ...
Moscow, Russia, 10 April 2015 - Today, Novo Nordisk opens a new manufacturing facility in Russia for formulation and filling of modern insulin for the treatment of diabetes. The production will cover ...
PARSIPPANY, N.J.--(BUSINESS WIRE)--The Medicines Company (NASDAQ:MDCO) today announced that the U.S. Food and Drug Administration (FDA) has approved a supplemental new drug application (sNDA) for a ...
Stability is a critical factor in drug formulation, with implications for product quality, lifecycle management, and ...
Ascletis Pharma Inc. (HKEX: 1672, "Ascletis") announces that it has selected ASC37 injection, a next-generation, once-monthly, subcutaneously administered GLP-1R/GIPR/GCGR[1] triple peptide agonist, ...
Credit: Baxter. Zosyn premix is supplied in 2.25g in 50mL, 3.375g in 50mL, and 4.5g in 100mL presentations. Baxter has announced the launch of a frozen premix formulation of Zosyn (piperacillin and ...
(MENAFN- JCN NewsWire) Eisai's Antiepileptic Drug Fycompa Injection Formulation Launched In Japan Addressing Medical Needs for Patients Who Cannot Take the Medication Orally TOKYO, Apr 17, 2024 - (JCN ...
WuXi STA, a subsidiary of WuXi AppTec, reports that a new parenteral formulation manufacturing line has started operation at the drug product site in Wuxi city, China. It is the second line opened ...
The National Pharmaceutical Pricing Authority (NPPA) has once again extended its mandate to Pune-based Serum Institute of India (SII) to continue manufacturing two of its scheduled formulations ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results